Trifunctional antibodies induce efficient antitumour activity with immune cells from head and neck squamous cell carcinoma patients after radio-chemotherapy treatment.
about
Trifunctional antibody ertumaxomab: Non-immunological effects on Her2 receptor activity and downstream signalingMonoclonal antibodies against human cancer stem cells.Antibodies directed against receptor tyrosine kinases: current and future strategies to fight cancer.Effects of radiation therapy on postoperative complications and adverse events in patients with head and neck reconstruction with flaps.[Immunotherapy of head and neck cancer. Current developments].Development and clinical application of anti-HER2 monoclonal and bispecific antibodies for cancer treatment.
P2860
Trifunctional antibodies induce efficient antitumour activity with immune cells from head and neck squamous cell carcinoma patients after radio-chemotherapy treatment.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Trifunctional antibodies induc ...... radio-chemotherapy treatment.
@en
Trifunctional antibodies induc ...... radio-chemotherapy treatment.
@nl
type
label
Trifunctional antibodies induc ...... radio-chemotherapy treatment.
@en
Trifunctional antibodies induc ...... radio-chemotherapy treatment.
@nl
prefLabel
Trifunctional antibodies induc ...... radio-chemotherapy treatment.
@en
Trifunctional antibodies induc ...... radio-chemotherapy treatment.
@nl
P2093
P2860
P1476
Trifunctional antibodies induc ...... radio-chemotherapy treatment.
@en
P2093
B Pogorzelski
C Lindemann
J Gosepath
P Schroeder
P2860
P2888
P304
P356
10.1007/S12094-011-0751-5
P577
2011-12-01T00:00:00Z